# Quality of Life in Multiple Myeloma Patients Treated With Bortezomib

> **NCT01021592** · — · COMPLETED · sponsor: **Janssen Korea, Ltd., Korea** · enrollment: 140 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** bortezomib

## Key facts

- **NCT ID:** NCT01021592
- **Lead sponsor:** Janssen Korea, Ltd., Korea
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2014-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01021592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01021592, "Quality of Life in Multiple Myeloma Patients Treated With Bortezomib". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01021592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*